Taxonomy Code 1835X0200X(1835x0200x)
Oncology Pharmacist. Providers: 18
Select City
B
L
O
Oncology Pharmacist Providers
| NPI | Name | Type | Address |
|---|---|---|---|
|
Cancer Partners Of Nebraska Pc |
Organization |
201 S 68th Street Pl Ste 200 Lincoln, NE |
|
|
Stephanie Johnson |
Individual |
1090 Nebraska Medicine Omaha, NE |
|
|
Lee Ann Mcclannan |
Individual |
989200 Nebraska Medicine Campus Zip 1090 Omaha, NE |
|
|
Chao Yuan Ku |
Individual |
505 S 45th St Omaha, NE |
|
|
DR. PHARMD Thomas Lloyd Davis |
Individual |
111 N 175th St Omaha, NE |
|
|
DR. PHARMD Rob Swaney |
Individual |
2500 Bellevue Medical Center Dr Bellevue, NE |
|
|
PHARMD Jared Matya |
Individual |
988149 Nebraska Medical Ctr Omaha, NE |
|
|
Ashley Mary Kenkel |
Individual |
505 S 45th St Omaha, NE |
|
|
DR. PHARMD Sarah Emily Medeiros |
Individual |
981090 Nebraska Medical Ctr Omaha, NE |
|
|
Kealy Marth |
Individual |
987400 Nebraska Medical Ctr Omaha, NE |
|
|
PHARMD Jessica Sobczyk |
Individual |
989200 Nebraska Medical Ctr Omaha, NE |
|
|
PHARMD Spencer Lehmann |
Individual |
989200 Nebraska Med Center Omaha, NE |
|
|
Amy Mayer |
Individual |
989200 Nebraska Medical Canter Omaha, NE |
|
|
PHARMD Veronica Ramirez |
Individual |
989200 Nebraska Medical Ctr Omaha, NE |
|
|
PHARMD Jeffrey Scott Norris |
Individual |
111 N 175th St Rm 20139 Omaha, NE |
|
|
Allison Graner |
Individual |
981090 Nebraska Medical Ctr Omaha, NE |
|
|
DR. PHARMD Subash C Baniya |
Individual |
989200 Nebraska Medical Ctr Omaha, NE |
|
|
PHARMD Daylan Storm |
Individual |
981090 Nebraska Medical Ctr Omaha, NE |
How to obtain, renew, or terminate an NPI
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
| Taxonomy Code | 1835X0200X |
| Specialization | Oncology |
| Display Name | Oncology Pharmacist |
| Taxonomy Group | Pharmacy Service Providers |
| Taxonomy Classification | Pharmacist |
| Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
| Effective Date | September 30, 2009 |